Figure 3.
Adjusted association between individual CHA 2 DS 2‐VASc factors and OAC use among those with CHA 2 DS 2‐VASc ≥2. Analyses were adjusted for other CHA 2 DS 2‐VASc variables and race, insurance (private vs nonprivate), mHAS‐BLED score, rhythm control therapy, total number of physicians at site, provider type (physician vs other provider), proportion of female patients at site, and clustering by practice and provider. CHF indicates congestive heart failure; OAC, oral anticoagulant; TIA, transient ischemic attack. Vascular Disease indicates peripheral vascular disease, history of myocardial infarction, prior coronary artery bypass, or prior percutaneous coronary intervention.